Neuroborreliosis - an epidemiological, clinical and healthcare cost study from an endemic area in the south-east of Sweden

Clinical Microbiology and Infection

Volumn 16, Issue 8, 2010, Pages 1245-1251

  Henningsson, A J ^a   Malmvall, B E ^a,b   Ernerudh, J ^b   Matussek, A ^a,c   Forsberg, P ^b  

^a RYHOV COUNTY HOSPITAL   (Sweden)

^b LINKÖPING UNIVERSITY   (Sweden)

^c ST GÖRAN S HOSPITAL   (Sweden)

Author keywords

Clinical; Epidemiology; Healthcare economy; Lyme disease; Neuroborreliosis

Indexed keywords

ALBUMIN; BACTERIUM ANTIBODY; BIOLOGICAL MARKER; CEFTRIAXONE; CEFUROXIME; DOXYCYCLINE; IMMUNOGLOBULIN G; PENICILLIN G;

ADOLESCENT; ADULT; AGE; AGED; ANTIBODY DETECTION; ARTHRALGIA; ARTICLE; BORRELIA BURGDORFERI; CEREBROSPINAL FLUID ANALYSIS; CEREBROSPINAL FLUID LEVEL; CHILD; CONCENTRATION LOSS; CONTROLLED STUDY; COST OF ILLNESS; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE MARKER; DISEASE SURVEILLANCE; DRUG COST; EARLY DIAGNOSIS; ENDEMIC DISEASE; FACIAL NERVE PARALYSIS; FEMALE; FEVER; FOLLOW UP; HEADACHE; HEALTH INSURANCE; HUMAN; INFANT; LENGTH OF STAY; LYME DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MYALGIA; PARESTHESIA; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; SWEDEN; TREATMENT DURATION; VERTIGO; BLOOD; CEREBROSPINAL FLUID; ECONOMICS; HEALTH CARE COST; INCIDENCE; LYME NEUROBORRELIOSIS; MIDDLE AGED; NEWBORN; PATHOLOGY; RETROSPECTIVE STUDY; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, BACTERIAL; CHILD; CHILD, PRESCHOOL; ENDEMIC DISEASES; FEMALE; HEALTH CARE COSTS; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; LYME NEUROBORRELIOSIS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SWEDEN; YOUNG ADULT;

EID: 77955128517     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2009.03059.x     Document Type: Article

References (33)

1. Berglund J, Eitrem R, Ornstein K. An epidemiologic study of Lyme disease in southern Sweden. N Engl J Med 1995, 333:1319-1327.
2. Cimmino MA. Relative frequency of Lyme borreliosis and of its clinical manifestations in Europe. European Community Concerted Action on Risk Assessment in Lyme Borreliosis. Infection 1998, 26:298-300.
3. Stanek G, O'Connell S, Cimmino M. European Union Concerted Action on Risk Assessment in Lyme Borreliosis: clinical case definitions for Lyme borreliosis. Wien Klin Wochenschr 1996, 108:741-747.
4. Kaiser R. Variable CSF findings in early and late Lyme neuroborreliosis: a follow-up study in 47 patients. J Neurol 1994, 242:26-36.
5. Oschmann P, Dorndorf W, Hornig C, Schafer C, Wellensiek HJ, Pflughaupt KW. Stages and syndromes of neuroborreliosis. J Neurol 1998, 245:262-272.
6. Weber K. Aspects of Lyme borreliosis in Europe. Eur J Clin Microbiol Infect Dis 2001, 20:6-13.
7. Berglund J, Stjernberg L, Ornstein K, Tykesson-Joelsson K, Walter H. 5-y Follow-up study of patients with neuroborreliosis. Scand J Infect Dis 2002, 34:421-425.
8. Vrethem M, Hellblom L, Widlund M. Chronic symptoms are common in patients with neuroborreliosis-a questionnaire follow-up study. Acta Neurol Scand 2002, 106:205-208.
9. Gustafson R. Epidemiological studies of Lyme borreliosis and tick-borne encephalitis. Scand J Infect Dis Suppl 1994, 92:1-63.
10. Gustafson R, Jaenson TG, Gardulf A, Mejlon H, Svenungsson B. Prevalence of Borrelia burgdorferi sensu lato infection in Ixodes ricinus in Sweden. Scand J Infect Dis 1995, 27:597-601.
11. Joss AW, Davidson MM, Ho-Yen DO, Ludbrook A. Lyme disease-what is the cost for Scotland? Public Health 2003, 117:264-273.
12. Peter BJ. Use and interpretation of tests in clinical immunology 1990, 7th edn, Omaha, NE, Interstate Press
13. Fernstrom M. http://www.socialstyrelsen.sehttp://www.nordclass.uu.se, Vad är DRG (cited 10 January 2008); available from and
14. NordDRG Manual System. http://www.nordclass.uu.se, (cited 2 November 2009); available from:
15. Westermark L, Rummukainen M, Nivrén A. Vintrarna är varmare. http://www.naturvardsverket.se, 2007 December 19 (cited 2008 January 8);
16. Alexandersson H. Klimat i förändring. 2006, http://www.smhi.se, (cited 8 January 2008);
17. Randolph SE. The shifting landscape of tick-borne zoonoses: tick-borne encephalitis and Lyme borreliosis in Europe. Phil Trans R Soc Lond B Biol Sci 2001, 356:1045-1056.
18. Kovats RS, Campbell-Lendrum DH, McMichael AJ, Woodward A, Cox JS. Early effects of climate change: do they include changes in vector-borne disease? Phil Trans R Soc Lond B Biol Sci 2001, 356:1057-1068.
19. Jaenson TG. The epidemiology of lyme borreliosis. Parasitol Today 1991, 7:39-45.
20. Duffy DC, Campbell SR, Clark D, DiMotta C, Gurney S. Ixodes scapularis (Acari: Ixodidae) deer tick mesoscale populations in natural areas: effects of deer, area, and location. J Med Entomol 1994, 31:152-158.
21. Talleklint L, Jaenson TG. Relationship between Ixodes ricinus density and prevalence of infection with Borrelia-like spirochetes and density of infected ticks. J Med Entomol 1996, 33:805-811.
22. Fryderyk S. Parasitic Acari of wild boar (Sus scrofa L.) from Pomerania lake district. Wiad Parazytol 2000, 46:163-168.
23. Arsrapport Viltovervakningen. 2005/2006, http://www.jagareforbundet.se, (cited 2008 January 15); available from:
24. Steere AC. Lyme disease. N Engl J Med 1989, 321:586-596.
25. Nadelman RB, Wormser GP. Lyme borreliosis. Lancet 1998, 352:557-565.
26. Stanek G, Strle F. Lyme borreliosis. Lancet 2003, 362:1639-1647.
27. Stiernstedt G, Gustafsson R, Karlsson M, Svenungsson B, Skoldenberg B. Clinical manifestations and diagnosis of neuroborreliosis. Ann NY Acad Sci 1988, 539:46-55.
28. Forsberg P, Ernerudh J, Ekerfelt C, Roberg M, Vrethem M, Bergstrom S. The outer surface proteins of Lyme disease borrelia spirochetes stimulate T cells to secrete interferon-gamma (IFN-gamma): diagnostic and pathogenic implications. Clin Exp Immunol 1995, 101:453-460.
29. Zeidner N, Dreitz M, Belasco D, Fish D. Suppression of acute Ixodes scapularis-induced Borrelia burgdorferi infection using tumor necrosis factor-alpha, interleukin-2, and interferon-gamma. J Infect Dis 1996, 173:187-195.
30. Kang I, Barthold SW, Persing DH, Bockenstedt LK. T-helper-cell cytokines in the early evolution of murine Lyme arthritis. Infect Immun 1997, 65:107-111.
31. Widhe M, Grusell M, Ekerfelt C, Vrethem M, Forsberg P, Ernerudh J. Cytokines in Lyme borreliosis: lack of early tumour necrosis factor-alpha and transforming growth factor-beta1 responses are associated with chronic neuroborreliosis. Immunology 2002, 107:46-55.
32. Sjowall J, Carlsson A, Vaarala O. Innate immune responses in Lyme borreliosis: enhanced tumour necrosis factor-alpha and interleukin-12 in asymptomatic individuals in response to live spirochetes. Clin Exp Immunol 2005, 141:89-98.
33. Lakemedels-behandling av borrelia infektion. 2009, 20(4). http://www.lakemedelsverket.se, (cited 2 November 2009); available from: